This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

17 Jul 2017

Technology adoption fuels growth for pharma tech firm

Company has experienced double digit growth across its automation, MES and managed services offering.

Zenith Technologies has strengthened its global workforce, recruiting 100 people over the past year in response to growing demand for manufacturing execution system (MES) and automation technology in the pharma sector.

The global life science technology firm, with headquarters in Cork and 16 offices worldwide, has experienced double digit growth across its automation, MES and managed services offering, which has been supported by around a 50% increase in headcount since 2014. It’s 700 plus strong team of engineers supports some of the world’s largest pharma firms with the implementation of new technology.

As demand for technology grows in the pharma sector against a backdrop of an industry-wide engineering skills shortage, Zenith is also investing in training future talent. The company has just made a record intake of more than 30 graduates from across Ireland, the UK, the US and Singapore.

Shea Fahy, HR director at Zenith commented: “Recruiting skilled and experienced staff is important for the future of our business and the growing adoption of technology in the life sciences space also demands engineers to ensure effective implementation and support solutions. We’re proud that our one-year graduate programme addresses the engineering skills gap head on, supporting the talent of the future.”

Graduates will benefit from an initial 2-week induction and 6-week mentoring session from experienced engineers, where they will learn to identify customer challenges and select the appropriate technological solutions.

“We have worked hard to build up a reputation as a trusted technology partner in the life sciences sector. Our employees have the opportunity to work with some of the largest pharmaceutical companies in the world, with a structured approach to continued learning and development to enhance their engineering skillset.

“We are incredibly proud of the growth we have been able to achieve. We will continue to strengthen our ability to support our customers and by the end of this year, we expect to have doubled our headcount from 2014,” Fahy continued.

Related News